Genius Group Limited — Form 6-K Summary
Business Context and Reporting Period
Genius Group Limited filed this Form 6-K for July 2023. The filing reports the results of the Company’s Annual Meeting of Stockholders held on July 12, 2023. Voting eligibility was based on share ownership as of June 9, 2023.
Financial and Operating Metrics
The filing does not provide current-period revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics. It records shareholder approval to receive and adopt the Directors’ Statement and audited financial statements for the year ended December 31, 2021.
Meeting Results and Material Changes
| Proposal | Result | Votes For | Votes Against |
|---|---|---|---|
| Adopt Directors’ Statement and audited financial statements for FY2021 | Approved | 14,604,509 | 406,707 |
| Approve directors’ fees and remuneration for FY2022 | Approved | 13,734,433 | 1,263,113 |
| Re-elect Roger James Hamilton | Approved | 14,506,807 | 538,514 |
| Re-elect Gong Ling Jun Anna | Approved | 14,486,698 | 526,958 |
| Re-elect Lim Kah Wui | Approved | 14,483,138 | 527,947 |
| Re-appoint Mazars LLP as auditor | Approved | 14,434,091 | 562,980 |
| Authorize the issuance of shares | Approved | 13,154,433 | 1,903,192 |
The most significant governance-related authorization was approval to issue shares, with 87.36% of votes cast in favor. The filing does not describe any issuance, transaction, dilution amount, or other material change resulting from this authorization.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no management guidance, business outlook, risk update, contingency disclosure, or unusual financial item. It does not state whether any shares were issued following the authorization.
Key Facts for Investor Verification
- Confirm the Company’s current financial position using its latest annual report or subsequent filings; this Form 6-K contains no current financial metrics.
- Review the FY2021 audited financial statements referenced in Proposal 1.
- Determine whether the authority to issue shares has been exercised and assess any resulting dilution.
- Verify the terms and amount of directors’ remuneration approved for FY2022.
- Confirm the continued appointment of Mazars LLP and review any subsequent auditor-related disclosures.